Popular weight loss drugs are now acknowledging the potential health risks right on the label. The FDA has updated the label of the diabetes drug Ozempic to acknowledge reports of blocked intestines and some people who use it. Ozempic and its sister weight loss drug, Wegovy, have recently soared in popularity.